Trial NCT01896999

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2013-01275
Secondary IDs: E4412 NCI-2013-01275 S14-00011 U10CA180820 U24CA196172

Last trial update was posted on 2024-04-16

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Brentuximab Vedotin Immunoconjugates Immunoglobulins Ipilimumab Nivolumab

MeSH Conditions

Hodgkin Disease Lymphoma

Other Conditions

Recurrent Classic Hodgkin Lymphoma Refractory Classic Hodgkin Lymphoma

Stopping Reasons

Other - Results of adult patient cohort released

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID